Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps
- PMID: 37002640
- DOI: 10.1111/apt.17495
Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps
Abstract
Background and aims: While post-inflammatory polyps (PIPs) have historically been a risk factor for colorectal neoplasia (CRN), histologic activity may explain this association. We aimed to assess the impact of histologic activity on CRN occurrence in IBD patients with colonic PIPs.
Methods: Patients with PIPs on surveillance colonoscopy at Saint-Antoine hospital between 1 January 1996 and 31 December 2020 were included and subsequent colonoscopies were assessed. Histologic IBD activity was assessed by the Nancy histologic index. Survival and Cox regression analysis were performed to assess the strength of the association of PIPs and other patient variables with progression to CRN.
Results: A total of 173 patients with at least two surveillance colonoscopies with PIPs at index colonoscopy were compared to a similar group of 252 patients without PIPs. In survival analysis, the presence or PIPs at index colonoscopy did not impact the risk of CRN in patients with histological inflammation (p = 0.83) and in patients without histological inflammation (p = 0.98). The risk of CRN was associated with increasing Nancy index score of 3 or 4 (HR: 4.16; 95% CI 1.50-11.52 and HR: 3.44; 95% CI 1.63-7.24), age (HR per 10-year increase: 1.37; 95% CI 1.13-1.66) and first-degree family history of colorectal cancer (HR: 5.87; v 1.31-26.26), but not PIPs (HR: 1.17; 95% CI 0.63-2.17).
Conclusions: After controlling for histologic activity, PIPs do not increase the risk of CRN in IBD patients. Histologic activity rather than PIPs should be considered in the risk assessment of CRN.
© 2023 John Wiley & Sons Ltd.
Comment in
-
Letter: histologic disease activity and colorectal neoplasia risk.Aliment Pharmacol Ther. 2023 Jun;57(12):1480. doi: 10.1111/apt.17528. Aliment Pharmacol Ther. 2023. PMID: 37243459 No abstract available.
-
Letter: histologic disease activity and colorectal neoplasia risk-authors' reply.Aliment Pharmacol Ther. 2023 Jun;57(12):1481. doi: 10.1111/apt.17536. Aliment Pharmacol Ther. 2023. PMID: 37243469 No abstract available.
-
Editorial: Pip pip to PIP's (post-inflammatory polyps) as a neoplasia risk factor in IBD?Aliment Pharmacol Ther. 2023 Aug;58(3):361-362. doi: 10.1111/apt.17565. Aliment Pharmacol Ther. 2023. PMID: 37452585 No abstract available.
References
REFERENCES
-
- Beaugerie L, Itzkowitz S. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441-52. https://doi.org/10.1056/NEJMra1403718
-
- Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982-1018. https://doi.org/10.1016/j.crohns.2013.09.016
-
- de Jong ME, Gillis VELM, Derikx LAAP, Hoentjen F. No increased risk of colorectal neoplasia in patients with inflammatory bowel disease and Postinflammatory polyps. Inflamm Bowel Dis. 2020;26(9):1383-9. https://doi.org/10.1093/ibd/izz261
-
- Wijnands AM, de Jong ME, Lutgens MWMD, Hoentjen F, Elias SG, Oldenburg B. Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis. Gastroenterology. 2021;160(5):1584-98. https://doi.org/10.1053/j.gastro.2020.12.036
-
- Mahmoud R, Shah SC, Ten Hove JR, et al. No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases. Gastroenterology. 2019;156(5):1333-1344.e3. https://doi.org/10.1053/j.gastro.2018.11.067
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous